US Patent 9018161 Protease resistant insulin analogues
Patent 9018161 was granted and assigned to Novo Nordisk on April, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 20, 2007
Date of Patent
April 28, 2015
Patent Application Number
12442190
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9018161 Protease resistant insulin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.